vs

Side-by-side financial comparison of Life360, Inc. (LIF) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.

Life360, Inc. is the larger business by last-quarter revenue ($146.0M vs $75.5M, roughly 1.9× PUMA BIOTECHNOLOGY, INC.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs 26.4%). Life360, Inc. produced more free cash flow last quarter ($36.6M vs $14.4M). Over the past eight quarters, Life360, Inc.'s revenue compounded faster (36.6% CAGR vs 31.3%).

Life360, Inc. develops family-focused safety and connectivity platforms. Core offerings include real-time location sharing, emergency alerts, driving behavior analysis tools and identity theft protection. It serves consumer markets across North America, Europe and Asia-Pacific, with most revenue from tiered premium subscription plans.

Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.

LIF vs PBYI — Head-to-Head

Bigger by revenue
LIF
LIF
1.9× larger
LIF
$146.0M
$75.5M
PBYI
Growing faster (revenue YoY)
PBYI
PBYI
+1.4% gap
PBYI
27.7%
26.4%
LIF
More free cash flow
LIF
LIF
$22.2M more FCF
LIF
$36.6M
$14.4M
PBYI
Faster 2-yr revenue CAGR
LIF
LIF
Annualised
LIF
36.6%
31.3%
PBYI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
LIF
LIF
PBYI
PBYI
Revenue
$146.0M
$75.5M
Net Profit
$129.7M
Gross Margin
75.1%
69.3%
Operating Margin
6.1%
22.7%
Net Margin
88.8%
Revenue YoY
26.4%
27.7%
Net Profit YoY
1425.9%
EPS (diluted)
$1.53
$0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LIF
LIF
PBYI
PBYI
Q4 25
$146.0M
$75.5M
Q3 25
$124.5M
$54.5M
Q2 25
$115.4M
$52.4M
Q1 25
$103.6M
$46.0M
Q4 24
$115.5M
$59.1M
Q3 24
$92.9M
$80.5M
Q2 24
$84.9M
$47.1M
Q1 24
$78.2M
$43.8M
Net Profit
LIF
LIF
PBYI
PBYI
Q4 25
$129.7M
Q3 25
$9.8M
$8.8M
Q2 25
$7.0M
$5.9M
Q1 25
$4.4M
$3.0M
Q4 24
$8.5M
Q3 24
$7.7M
$20.3M
Q2 24
$-11.0M
$-4.5M
Q1 24
$-9.8M
$-4.8M
Gross Margin
LIF
LIF
PBYI
PBYI
Q4 25
75.1%
69.3%
Q3 25
78.0%
77.7%
Q2 25
78.4%
76.5%
Q1 25
80.6%
77.1%
Q4 24
74.0%
76.4%
Q3 24
75.4%
63.9%
Q2 24
75.0%
77.4%
Q1 24
76.7%
75.5%
Operating Margin
LIF
LIF
PBYI
PBYI
Q4 25
6.1%
22.7%
Q3 25
4.6%
17.6%
Q2 25
1.7%
12.7%
Q1 25
2.1%
8.7%
Q4 24
4.9%
22.6%
Q3 24
-5.3%
27.4%
Q2 24
-2.8%
-4.6%
Q1 24
-8.2%
-5.3%
Net Margin
LIF
LIF
PBYI
PBYI
Q4 25
88.8%
Q3 25
7.9%
16.2%
Q2 25
6.1%
11.2%
Q1 25
4.2%
6.5%
Q4 24
7.4%
Q3 24
8.3%
25.2%
Q2 24
-12.9%
-9.6%
Q1 24
-12.5%
-11.0%
EPS (diluted)
LIF
LIF
PBYI
PBYI
Q4 25
$1.53
$0.26
Q3 25
$0.11
$0.17
Q2 25
$0.08
$0.12
Q1 25
$0.05
$0.06
Q4 24
$0.14
$0.40
Q3 24
$0.09
$0.41
Q2 24
$-0.15
$-0.09
Q1 24
$-0.14
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LIF
LIF
PBYI
PBYI
Cash + ST InvestmentsLiquidity on hand
$494.3M
$97.5M
Total DebtLower is stronger
$22.7M
Stockholders' EquityBook value
$548.2M
$130.3M
Total Assets
$959.7M
$216.3M
Debt / EquityLower = less leverage
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LIF
LIF
PBYI
PBYI
Q4 25
$494.3M
$97.5M
Q3 25
$455.7M
$94.4M
Q2 25
$432.7M
$96.0M
Q1 25
$168.9M
$93.2M
Q4 24
$159.2M
$101.0M
Q3 24
$159.0M
$96.7M
Q2 24
$160.8M
$96.8M
Q1 24
$73.4M
$107.2M
Total Debt
LIF
LIF
PBYI
PBYI
Q4 25
$22.7M
Q3 25
$34.0M
Q2 25
$45.3M
Q1 25
$56.7M
Q4 24
$68.0M
Q3 24
$79.3M
Q2 24
$90.7M
Q1 24
$5.2M
$102.0M
Stockholders' Equity
LIF
LIF
PBYI
PBYI
Q4 25
$548.2M
$130.3M
Q3 25
$391.4M
$115.3M
Q2 25
$366.7M
$104.7M
Q1 25
$376.3M
$97.1M
Q4 24
$358.5M
$92.1M
Q3 24
$339.7M
$71.1M
Q2 24
$326.7M
$48.5M
Q1 24
$239.8M
$51.0M
Total Assets
LIF
LIF
PBYI
PBYI
Q4 25
$959.7M
$216.3M
Q3 25
$787.5M
$202.9M
Q2 25
$753.6M
$194.9M
Q1 25
$455.4M
$196.2M
Q4 24
$441.6M
$213.3M
Q3 24
$427.4M
$220.7M
Q2 24
$405.9M
$205.0M
Q1 24
$318.8M
$214.1M
Debt / Equity
LIF
LIF
PBYI
PBYI
Q4 25
0.17×
Q3 25
0.30×
Q2 25
0.43×
Q1 25
0.58×
Q4 24
0.74×
Q3 24
1.12×
Q2 24
1.87×
Q1 24
0.02×
2.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LIF
LIF
PBYI
PBYI
Operating Cash FlowLast quarter
$36.8M
$14.4M
Free Cash FlowOCF − Capex
$36.6M
$14.4M
FCF MarginFCF / Revenue
25.1%
19.1%
Capex IntensityCapex / Revenue
0.2%
0.0%
Cash ConversionOCF / Net Profit
0.28×
TTM Free Cash FlowTrailing 4 quarters
$86.8M
$41.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LIF
LIF
PBYI
PBYI
Q4 25
$36.8M
$14.4M
Q3 25
$26.4M
$9.7M
Q2 25
$13.3M
$14.1M
Q1 25
$12.1M
$3.6M
Q4 24
$12.3M
$15.6M
Q3 24
$6.3M
$11.0M
Q2 24
$3.3M
$1.0M
Q1 24
$10.7M
$11.2M
Free Cash Flow
LIF
LIF
PBYI
PBYI
Q4 25
$36.6M
$14.4M
Q3 25
$25.6M
$9.7M
Q2 25
$12.7M
$14.1M
Q1 25
$11.9M
$3.6M
Q4 24
$11.2M
$15.6M
Q3 24
$6.3M
$11.0M
Q2 24
$3.2M
$1.0M
Q1 24
FCF Margin
LIF
LIF
PBYI
PBYI
Q4 25
25.1%
19.1%
Q3 25
20.6%
17.7%
Q2 25
11.0%
26.8%
Q1 25
11.5%
7.7%
Q4 24
9.7%
26.4%
Q3 24
6.8%
13.7%
Q2 24
3.8%
2.1%
Q1 24
Capex Intensity
LIF
LIF
PBYI
PBYI
Q4 25
0.2%
0.0%
Q3 25
0.6%
0.0%
Q2 25
0.6%
0.0%
Q1 25
0.1%
0.1%
Q4 24
1.0%
0.0%
Q3 24
0.0%
0.0%
Q2 24
0.1%
0.0%
Q1 24
0.0%
0.0%
Cash Conversion
LIF
LIF
PBYI
PBYI
Q4 25
0.28×
Q3 25
2.70×
1.10×
Q2 25
1.90×
2.41×
Q1 25
2.75×
1.21×
Q4 24
1.45×
Q3 24
0.83×
0.54×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons